VAR2 Pharmaceuticals

... is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications.

About VAR2 Pharmaceuticals

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.

The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.

Read more
19 September 2018
Uncategorized
It is with great pleasure we can announce that Dr. Nader Al-Nakouzi was awarded The FEBS Journal Best Poster Prize for the poster "Expression and regulation of oncofetal chondroitin sulfate in prostate cancer" at the  Cellular signalling and cancer therapy EMBO workshop in Cavtat...
16 September 2018
Uncategorized
Co-founder and executive Chairman of the Board of directors, Dr. Mads Daugaard, are to present data on VAR2-based immunotherapy in the context of the cancer microenvironemnt at the 9th CDD Conference on Cancer, taking place in London, September 17-19, 2018. The title of the talk is "Targeting o...
13 September 2018
Uncategorized
Our Research Scientist Dr. Nader Al-Nakouzi, will present new exciting data on oncofetal Chondrotin sulfat A in prostate cancer at the Cellular signalling and cancer therapy EMBO workshop, taking place in Cavtat, Croatia 14-18 September 2018.  ...
10 September 2018
Uncategorized

VAR2 Pharmaceuticals/VarCT Diagnostics will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.

Our Investors

VAR2 Pharmaceuticals is owned by the inventor group and University of Copenhagen, and we are financed by private investors.

Read More

Want to be a partner?

To discuss a potential partnership opportunity with VAR2 Pharmaceuticals please contact us

Read more